Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Details)

v3.10.0.1
Subsequent Events - Additional Information (Details)
$ in Thousands
Aug. 14, 2018
USD ($)
Pfizer License Agreement | SUlopenem for Resistant Enterobacteriaceae (SURE) 1 | Subsequent Event  
Subsequent Event [Line Items]  
Liability on achieving milestones $ 7,500